已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Incidence and predictors of major bleeding among patients receiving apixaban or aspirin for subclinical atrial fibrillation: insights from the ARTESiA sub-analysis

阿哌沙班 心房颤动 阿司匹林 亚临床感染 医学 入射(几何) 内科学 心脏病学 华法林 拜瑞妥 物理 光学
作者
Deborah M. Siegal,Jeff S. Healey,William F. McIntyre,David Conen,Michael Robert Gold,Christopher Bull Granger,Jens Cosedis Nielsen,DANIEL M. WOJDYLA,Renato D. Lópes
出处
期刊:Europace [Oxford University Press]
卷期号:27 (Supplement_1)
标识
DOI:10.1093/europace/euaf085.499
摘要

Abstract Background ARTESiA (Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation) was a randomized double-blind, double-dummy trial which showed that apixaban, compared with aspirin, reduced stroke and systemic embolism, but increased major bleeding in patients aged ≥55 years with subclinical atrial fibrillation (AF) and CHA2DS2-VASc score ≥3. Objectives To characterize major bleeding events, determine the cumulative incidence of major bleeding (overall and by treatment, site, and severity), and determine risk factors associated with major bleeding. Study Design and Methods: We performed a pre-specified sub-analysis of major bleeding events defined as overt bleeding accompanied by a decrease in hemoglobin of ≥2 g/dL or transfusion of ≥2 units of packed red cells, occurring at a critical site, or resulting in death (International Society on Thrombosis and Haemostasis criteria) in the on-treatment population. Results After mean follow-up of 3.5 years, major bleeding occurred in 86/1989 patients on apixaban (1.71% per patient-year) and 47/1972 patients on aspirin (0.95% per patient-year) (HR 1.80; 95% CI, 1.26 to 2.57; p=0.001) (Table 1). Gastrointestinal bleeding was most common, representing 52.3% of bleeds in the apixaban group and 42.5% of bleeds in the aspirin group. The frequency of intracranial (0.6% vs. 0.8%, p=0.547) and fatal bleeding (0.3% vs. 0.2%, p=0.40) was low and similar between groups, while major gastrointestinal bleeding was more frequent in patients on apixaban (2.3% vs. 1.0%, p=0.002). The cumulative incidence of major bleeding is shown in Figure 1 according to randomized treatment, bleeding site and severity. Most bleeding events (73.8%) were not considered severe or fatal. Baseline covariates associated with an increased risk of major bleeding included ongoing cancer (HR 3.10, 95%CI 1.61-5.96), randomization to apixaban (HR 1.83, 95%CI 1.28-2.62), and age (HR 1.45, 95%CI 1.27-1.65, for each increase of 5 years). Conclusions The increased risk of major bleeding with apixaban is driven by gastrointestinal bleeding. Almost 75% of major bleeds were not considered emergencies and required only supportive measures. Increasing age and active cancer were associated with increased risk of major bleeding.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英姑的应助被秃头泡泡采纳,获得10
刚刚
1秒前
123发布了新的文献求助10
1秒前
三岁半完成签到 ,获得积分10
2秒前
江就的应助被why采纳,获得10
2秒前
2秒前
2秒前
嗦了一碗粉完成签到,获得积分10
3秒前
英俊的铭的应助被dd采纳,获得10
4秒前
朴素的尔蝶完成签到 ,获得积分10
4秒前
4秒前
小马甲的应助被whz采纳,获得10
5秒前
5秒前
5秒前
科研通AI6.3的应助被chiyudawang采纳,获得10
6秒前
ovo完成签到 ,获得积分10
7秒前
豌豆儿完成签到 ,获得积分10
7秒前
qqxs发布了新的文献求助10
8秒前
9秒前
10秒前
李健的应助被小鱼采纳,获得10
11秒前
11秒前
粗心的羽毛完成签到,获得积分0
12秒前
Akim的应助被风吹麦浪采纳,获得10
12秒前
20250702发布了新的文献求助30
12秒前
江奖姜酱完成签到,获得积分20
14秒前
今后的应助被医生采纳,获得10
14秒前
科科完成签到,获得积分10
14秒前
14秒前
lauwl8完成签到,获得积分10
14秒前
Ava的应助被斯文明杰采纳,获得10
14秒前
Owen的应助被黎礼采纳,获得10
15秒前
15秒前
16秒前
Darren发布了新的文献求助20
17秒前
17秒前
深情安青的应助被狂野采波采纳,获得10
18秒前
小鱼完成签到,获得积分10
19秒前
19秒前
张真狗发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179198
求助须知:如何正确求助?哪些是违规求助? 9569781
关于积分的说明 21806509
捐赠科研通 7774542
什么是DOI,文献DOI怎么找? 3433008
关于科研通互助平台的介绍 2556929
邀请新用户注册赠送积分活动 2478652